STOCKHOLM (Reuters) – Radiation therapy equipment maker Elekta posted on Wednesday an unexpected rise in quarterly profit despite headwinds from global supply chain issues, Russia’s invasion of Ukraine and pandemic lockdowns in China. Operating profit in the Swedish group’s fiscal fourth quarter grew to 570 million crowns ($58.3 million) from a year-ago 545 million on 5% sales growth. Analysts polled by Refinitiv had on average forecast a drop in profit to 525 million. [L5N2XF0J9] “The constraints in global supply chains continued, now also impacted by the war in Ukraine and lockdowns in China…